Roche, a global healthcare company, in partnership with Oncopadi Technologies, has introduced a new initiative aimed at supporting breast cancer patients across the country. The Breast Cancer Access Navigation and Testing Programme is designed to assist 5,000 individuals by enhancing early detection and providing precise diagnoses.
The initiative includes offering free immunohistochemistry testing, a critical tool in the accurate identification of breast cancer types. This program seeks to alleviate barriers to access and improve the quality of care for breast cancer patients, ultimately contributing to better health outcomes.
Source: Read more